Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pollack

Showing results (281-290 of 601) with videos related to

Pageof 61
Sort By:
JAMA|June 28, 2001
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectivenessS J Goldie, L Kuhn, L Denny, et al.
Journal of Pediatric Ophthalmology and Strabismus|November 1, 1991
Laser treatment of eye disorders in childrenA Pollack, H Leiba, D Soroker, et al.
Urology|November 1, 1994
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancerA Pollack, G K Zagars, A K el-Naggar, et al.
New Directions for Mental Health Services|January 1, 1993
Managed mental health in the Oregon Health PlanB H McFarland, R A George, D A Pollack, et al.
Psychiatric Services (Washington, D.C.)|July 16, 2005
Outcomes of patients in a low-intensity, short-duration involuntary outpatient commitment programDavid A Pollack, Bentson H McFarland, Jo M Mahler, et al.
Medical Care|January 17, 2007
The impact of managed care enrollment on emergency department use among children with special health care needsHarold A Pollack, John R C Wheeler, Anne Cowan, et al.
Eye (London, England)|October 5, 2001
Optic nerve head blood flow measurements in non-arteritic anterior ischaemic optic neuropathyH Leiba, R Rachmiel, A Harris, et al.
Cancer|April 1, 1994
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapyG K Zagars, F B Geara, A Pollack, et al.
The Journal of Urology|May 1, 1994
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcomeG K Zagars, M E Sands, A Pollack, et al.
Addiction (Abingdon, England)|August 27, 2025
Removing arbitrary limitations on buprenorphine for opioid use disorderNicole Gastala, Brianna Hudak, Mai T Pho, et al.
Pageof 61

Showing results (281-290 of 601) with videos related to

Sort By:
Pageof 61
JAMA|June 28, 2001
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectivenessS J Goldie, L Kuhn, L Denny, et al.
Journal of Pediatric Ophthalmology and Strabismus|November 1, 1991
Laser treatment of eye disorders in childrenA Pollack, H Leiba, D Soroker, et al.
Urology|November 1, 1994
Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancerA Pollack, G K Zagars, A K el-Naggar, et al.
New Directions for Mental Health Services|January 1, 1993
Managed mental health in the Oregon Health PlanB H McFarland, R A George, D A Pollack, et al.
Psychiatric Services (Washington, D.C.)|July 16, 2005
Outcomes of patients in a low-intensity, short-duration involuntary outpatient commitment programDavid A Pollack, Bentson H McFarland, Jo M Mahler, et al.
Medical Care|January 17, 2007
The impact of managed care enrollment on emergency department use among children with special health care needsHarold A Pollack, John R C Wheeler, Anne Cowan, et al.
Eye (London, England)|October 5, 2001
Optic nerve head blood flow measurements in non-arteritic anterior ischaemic optic neuropathyH Leiba, R Rachmiel, A Harris, et al.
Cancer|April 1, 1994
The T classification of clinically localized prostate cancer. An appraisal based on disease outcome after radiation therapyG K Zagars, F B Geara, A Pollack, et al.
The Journal of Urology|May 1, 1994
Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcomeG K Zagars, M E Sands, A Pollack, et al.
Addiction (Abingdon, England)|August 27, 2025
Removing arbitrary limitations on buprenorphine for opioid use disorderNicole Gastala, Brianna Hudak, Mai T Pho, et al.
Pageof 61